Prenetics Global Limited

NASDAQ: PRE
Nasdaq Stock Market
Healthcare Diagnostics & Research
Global Rank
#24520
Country Rank
#375
Market Cap
104.27 M
Price
8
Change (%)
0.87%
Volume
72,770

Prenetics Global Limited's latest marketcap:

104.27 M

As of 08/02/2025, Prenetics Global Limited's market capitalization has reached $104.27 M. According to our data, Prenetics Global Limited is the 24520th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 104.27 M
Revenue (ttm) 41.52 M
Net Income (ttm) -48,126,000
Shares Out 13.03 M
EPS (ttm) -3.8
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 08/02/2025

Prenetics Global Limited's yearly market capitalization.

Prenetics Global Limited has seen its market value drop from $1.68 B to $104.27 M since 2021, representing a total decrease of 93.78% and an annual compound decline rate (CAGR) of 53.88%.
Date Market Cap($) Change (%) Global Rank
08/02/2025 $104.27 M 48.07% 24520
12/31/2024 $70.86 M -0.24% 25572
12/29/2023 $71.03 M -68% 25371
12/30/2022 $221.96 M -86.75% 17405
12/31/2021 $1.68 B 6843

Company Profile

About Prenetics Global Limited

Prenetics Global Limited is a forward-thinking health sciences company dedicated to advancing both consumer and clinical health through innovative solutions.

Consumer Health Initiatives

  • IM8: A leading health and wellness brand driving consumer-focused health initiatives.
  • CircleDNA: Utilizes next-generation sequencing (NGS) technology to provide comprehensive consumer DNA testing for preventive health insights.

Clinical Health & Genomic Solutions

The company specializes in multi-cancer early detection technologies and offers a suite of genomic profiling panels, including:

  • ACTOnco
  • ACT HRD
  • ACTFusion
  • ACTDrug

Advanced Diagnostic & Monitoring Solutions

  • ACTLiquid Pro: A sequencing-based liquid biopsy assay for pan-solid tumors.
  • ACTMonitor: Provides real-time monitoring of drug resistance, treatment response, and cancer recurrence.
  • ACT Risk: A specialized solution for managing cancer risk.

Additional Ventures

Prenetics is also engaged in sports distribution, supplying high-quality sports nutrition products to fitness facilities.

Global Presence

Founded in 2014 and headquartered in Quarry Bay, Hong Kong, the company operates across Taiwan, Hong Kong, the United Kingdom, and internationally, with a presence in the United States.

Frequently Asked Questions

  • What is Prenetics Global Limited's (PRE) current market cap?
    As of 08/02/2025, Prenetics Global Limited (including the parent company, if applicable) has an estimated market capitalization of $104.27 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Prenetics Global Limited global market capitalization ranking is approximately 24520 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.